|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|---|---|
| Assets: | |||||
| Current assets | |||||
| Cash | |||||
| Prepaid expenses | |||||
| Short-term prepaid insurance | |||||
| Total current assets | |||||
| Deferred offering costs | |||||
| Long-term prepaid insurance | |||||
| Cash and marketable securities held in Trust Account | |||||
| Total Assets | |||||
| Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit) | |||||
| Current liabilities | |||||
| Accrued expenses | |||||
| Accounts payable and accrued expenses | |||||
| Accrued offering costs | |||||
| Advances from related party | |||||
| Promissory note - related party | |||||
| Related Party | |||||
| Total promissory note - related party | |||||
| Total current liabilities | |||||
| Deferred legal fees | |||||
| Total Liabilities | |||||
| Class A ordinary shares subject to possible redemption, 25,300,000 shares and no shares at a redemption value of $10.26 and $0 per share as of September 30, 2026 and December 31, 2025, respectively | |||||
| Shareholders’ Equity (Deficit) | |||||
| Ordinary shares, value | |||||
| Class A Ordinary Shares | |||||
| Class B Ordinary Shares | |||||
| Additional paid-in capital | |||||
| Retained earnings (accumulated deficit) | |||||
| Total Shareholders’ Equity (Deficit) | |||||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit) |
Loading...